Perioperative Risk Factors Related to the Prognosis of Lung Transplantation: A Retrospective Study
Launched by ZHEJIANG UNIVERSITY · Apr 3, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how factors related to anesthesia during lung transplantation can affect patients' recovery and outcomes. The study will analyze data from patients aged 18 and older who had either a single or double lung transplant at a specific hospital between 2017 and 2024. Researchers want to understand how anesthesia management impacts complications that may arise after surgery, how long patients stay in the intensive care unit (ICU), and overall recovery time in the hospital.
To participate in this study, individuals must be at least 18 years old and have received a lung transplant, but those who have had a re-transplant, multiple organ transplants, or incomplete medical records will not be eligible. If you or a loved one is considering a lung transplant, this trial aims to improve the process and outcomes of surgery by providing valuable insights into how anesthesia affects recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>18 years at time of transplantation
- • Received single or bilateral lung transplantation
- Exclusion Criteria:
- • Re-transplantation
- • Multi-organ transplantation
- • Autotransplantation
- • Incomplete medical records: Recipients with \>20% missing essential data elements in any of these categories:Preoperative baseline characteristics； Intraoperative parameters；Postoperative outcome measures
About Zhejiang University
Zhejiang University is a prestigious research institution located in Hangzhou, China, renowned for its commitment to advancing medical science and healthcare innovation. With a strong emphasis on interdisciplinary collaboration and cutting-edge research, the university plays a pivotal role in the development and execution of clinical trials aimed at improving patient outcomes and enhancing therapeutic approaches. Leveraging its extensive resources and expertise, Zhejiang University is dedicated to fostering advancements in medical knowledge while ensuring the highest standards of ethical conduct and scientific rigor in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported